Glamyo Health is a technology company.
Glamyo Health has raised $3.0M across 1 funding round.
Glamyo Health has raised $3.0M in total across 1 funding round.
Glamyo Health has raised $3.0M in total across 1 funding round.
Glamyo Health's investors include Agility Ventures, First Round Capital, Token Amigo.
Glamyo Health is a multi-specialty healthcare provider in India specializing in elective and cosmetic surgeries, offering services like laser proctology, laparoscopic surgeries, urology, and circumcision through a network of hospitals and clinics.[1][2][3] Founded around 2019-2020, it targets patients facing backlogged procedures, solving key issues of affordability, accessibility, and quality in secondary medical care by partnering with 500+ hospitals and 600 surgeons across 10+ cities including Delhi, Mumbai, Bangalore, and Hyderabad.[1][2] With $6M in total funding (including a $3.2M round), the company has shown growth momentum, employing 106 people, generating ₹3.7 Cr+ revenue in FY21, and planning expansion to 45 cities while facilitating INR 100 crore in healthcare financing.[1][2][5]
Glamyo Health was co-founded in January 2020 (with sources varying slightly to 2019) by Archit Garg and Dr. Preet Pal Thakur, who identified gaps in elective surgery access amid India's healthcare challenges.[1][2][5] Dr. Thakur, a medical professional, and Garg leveraged post-lockdown demand for backlogged procedures, pivoting from initial telemedicine explorations to a full platform for minimally invasive surgeries.[1][5] Early traction came via affordable laser treatments for 30+ conditions, rapid city expansions post-2020, and securing $3.2M funding, enabling partnerships with high-quality surgeons and setting ambitious goals like reaching 1 million patients in the first year.[1]
Glamyo Health rides the India health tech boom in elective surgeries, fueled by rising middle-class demand, post-COVID backlogs, and digital health adoption amid a $372B healthcare market growing at 22% CAGR.[1][2] Timing aligns with government pushes for affordable secondary care and fintech integrations for financing, positioning it against competitors like Pristyn Care and Ayu Health in a fragmented space.[2] By scaling to 45 cities, it democratizes specialist access, influences ecosystem standards for quality elective care, and boosts surgeon utilization, contributing to India's shift toward tech-enabled, outcome-based healthcare.[1]
Glamyo Health is poised for aggressive expansion, targeting 45 cities and 1M patients with Series B momentum ($5.5M+ raised), potentially hitting unicorn trajectory if it sustains 106-employee growth and revenue scaling beyond FY21's ₹3.7 Cr.[1][2][5] Trends like AI-driven diagnostics, insurance tie-ups, and laser tech adoption will shape its path, evolving its influence from regional disruptor to national leader in affordable surgery tech. As secondary care demand surges, expect deeper ecosystem impact through surgeon networks and financing innovations, amplifying its role in accessible health for millions.
Glamyo Health has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Series A in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2021 | $3.0M Series A | Agility Ventures, First Round Capital, Token Amigo |